Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 26 Genitourinary 12 Other hematologic neoplasm 6 Breast 6 Gynecologic 5 Thoracic 2 Plasma cell 2 Lymphoid 2 Head & Neck 2 Other 1 NET 1 Myeloid 1 Endocrine 1 CNS 1

Conditions

Brain Neoplasms 2306 Glioblastoma 2010 Glioma 1397 Central Nervous System Neoplasms 692 Astrocytoma 667 Neuroblastoma 647 Gliosarcoma 480 Neoplasms 405 Oligodendroglioma 404 Breast Neoplasms 327 Medulloblastoma 307 Carcinoma, Non-Small-Cell Lung 254 Meningioma 229 Recurrence 223 Sarcoma 214 Melanoma 206 Neoplasm Metastasis 202 Lung Neoplasms 198 Ependymoma 198 Neurofibromatosis 1 169 Lymphoma 161 Meningeal Carcinomatosis 138 Osteosarcoma 134 Ovarian Neoplasms 132 Wilms Tumor 123 Precursor Cell Lymphoblastic Leukemia-Lymphoma 123 Head and Neck Neoplasms 117 Lymphoma, Non-Hodgkin 116 Diffuse Intrinsic Pontine Glioma 113 Rhabdomyosarcoma 106

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Frailty × CNS × Clear all

NCT02530749 2019-07-11

Frailty as a Predictor of Neurosurgical Outcomes in Brain Tumor Patients

University of Colorado, Denver

Frailty, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡